These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

181 related items for PubMed ID: 30182835

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27. The expression profile and clinic significance of the SIX family in non-small cell lung cancer.
    Liu Q, Li A, Tian Y, Liu Y, Li T, Zhang C, Wu JD, Han X, Wu K.
    J Hematol Oncol; 2016 Nov 08; 9(1):119. PubMed ID: 27821176
    [Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29. Expression of MMP-7, MMP-9, TIMP-1 and TIMP-2 mRNA in lung tissue of patients with non-small cell lung cancer (NSCLC) and benign pulmonary disease.
    Safranek J, Pesta M, Holubec L, Kulda V, Dreslerova J, Vrzalova J, Topolcan O, Pesek M, Finek J, Treska V.
    Anticancer Res; 2009 Jul 08; 29(7):2513-7. PubMed ID: 19596921
    [Abstract] [Full Text] [Related]

  • 30. The prognostic significance of CD63 expressionin patients with non-small cell lung cancer.
    Koh H, An H, Jung J, Song D.
    Pol J Pathol; 2019 Jul 08; 70(3):183-188. PubMed ID: 31820861
    [Abstract] [Full Text] [Related]

  • 31. Investigation of serum miR-411 as a diagnosis and prognosis biomarker for non-small cell lung cancer.
    Wang SY, Li Y, Jiang YS, Li RZ.
    Eur Rev Med Pharmacol Sci; 2017 Sep 08; 21(18):4092-4097. PubMed ID: 29028091
    [Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37. Prognostic impact of elevation of vascular endothelial growth factor family expression in patients with non-small cell lung cancer: an updated meta-analysis.
    Zheng CL, Qiu C, Shen MX, Qu X, Zhang TH, Zhang JH, Du JJ.
    Asian Pac J Cancer Prev; 2015 Sep 08; 16(5):1881-95. PubMed ID: 25773840
    [Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40. Determination of the serum matrix metalloproteinase-9 (MMP-9) and tissue inhibitor of matrix metalloproteinase-1 (TIMP-1) in patients with either advanced small-cell lung cancer or non-small-cell lung cancer prior to treatment.
    Jumper C, Cobos E, Lox C.
    Respir Med; 2004 Feb 08; 98(2):173-7. PubMed ID: 14971882
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 10.